《大行报告》花旗下调中国铁塔(00788.HK)目标价至1.2元 评级「中性」
花旗发表报告,指中国铁塔(00788.HK)管理层预计未来核心业务有稳定的增长,5G基站的收入贡献将会增加。但该行认为由於电讯公司努力的成本控制,中国铁塔可能不会从5G方面获得巨大的收入增长杠杆,目标价由1.35元下调至1.2元,评级「中性」。
花旗指,中国铁塔管理层在投资者会议上表示,随着信息化、数字化和新能源应用带来的机遇,跨行业站址应用与信息业务(TSSAI)和能源运营业务的收入贡献占比将增加1个百分点,目标是在今年保持稳定的EBITDA利润率,并预计EBITDA利润率将随着更多TSSAI业务的租户和更多付费用户长期使用公司的备用电源和电池交换服务而得到改善。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.